NovaBay Pharmaceuticals, Inc. (NBY) Dividend Yield, History & Forecast

NovaBay Pharmaceuticals, Inc. (NBY) is a Biotechnology company in the Healthcare sector listed on the New York Stock Exchange Arca. It pays a current dividend yield of 322.58% ($4.00 per share annually (TTM)). The most recent ex-dividend date was September 30, 2025. The trailing twelve-month payout ratio is 92.2%; the market capitalization is approximately $52M.

Loading quote...

Frequently Asked Questions about NovaBay Pharmaceuticals, Inc. (NBY)

What is NovaBay Pharmaceuticals, Inc.'s dividend yield?
NovaBay Pharmaceuticals, Inc. (NBY) pays a current trailing twelve-month dividend yield of 322.58%, which works out to $4.00 per share annually based on the most recent payout schedule.
When does NovaBay Pharmaceuticals, Inc. pay its next dividend?
The most recent ex-dividend date was September 30, 2025.
Is NovaBay Pharmaceuticals, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is NovaBay Pharmaceuticals, Inc. in?
NovaBay Pharmaceuticals, Inc. (NBY) operates in the Healthcare sector, specifically the Biotechnology industry.
What is NovaBay Pharmaceuticals, Inc.'s dividend payout ratio?
NovaBay Pharmaceuticals, Inc. (NBY)'s trailing twelve-month dividend payout ratio is 92.2%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.